A carregar...
Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy
Immunotherapy agents in metastatic non-small cell lung cancer (NSCLC) can result in improved quality of life and survival when compared with platinum-based chemotherapy. Novel response patterns such as pseudoprogression and hyperprogression, however, have been described and pose a challenge to treat...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5864602/ https://ncbi.nlm.nih.gov/pubmed/29607190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.79 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|